IRNDP Conference 2019

IRNDP held its first conference on the 14th and 15th of October, 2019 in Sydney.  A big thank you to everyone who attended! There was a fantastic range of speakers from the United States, Canada, Sweden, Thailand, Malaysia and Australia and a massive spread of 140 registered delegates from Denmark, Canada, United States, Sweden, Malaysia, Bangladesh, Thailand Read more…

IRNDP Special Issue

We are delighted to announce that the fully open access IRNDP special issue of the Journal of Alzheimer’s Disease has now been released. The special issue focuses exclusively on dementia prevention and represents a substantial and wide ranging collection of evidence. The issue draws together articles and commentaries from members Read more…

From Cell Culture to Populations: Evidence that a group of pain-relievers slow Alzheimer’s disease progression

New research has come out showing that a group of nonsteroidal anti-inflammatory drugs (NSAID) may have therapeutic effects for Alzheimer’s Disease. Dr Jack Rivers-Auty and his team have been investigating the impact of nonsteroidal anti-inflammatory drugs (NSAIDs) in reducing neuroinflammation. Using mice models Jack and his team have found that the Read more…

Risk assessment and its role in prevention of dementia: lessons learned from other non-communicable diseases

Continuing our series of science commentaries Barbora Silarova and  Rachel Collins from the Universities of Exeter, UK and UNSW, Australia, consider whether lessons can be learned from other non-communicable diseases…   Dementia represents one of the biggest challenges for health and social care this century [1]. Since the development of Read more…